Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission

scientific article

Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1176/APPI.AJP.161.11.2108
P8608Fatcat IDrelease_pgjaa74fw5hhjls7spffa4wiwe
P698PubMed publication ID15514413

P50authorMary C. ZanariniQ60616491
Frances Rachel FrankenburgQ60646412
D Bradford ReichQ107533282
P2093author name stringJohn Hennen
Kenneth R Silk
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
borderline personality disorderQ208166
comorbidityQ1414874
P304page(s)2108-2114
P577publication date2004-11-01
P1433published inAmerican Journal of PsychiatryQ1935368
P1476titleAxis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission
P478volume161

Reverse relations

cites work (P2860)
Q34554331A Focused Systematic Review of Pharmacological Treatment for Borderline Personality Disorder
Q64993200A Life Span Perspective on Borderline Personality Disorder.
Q36135336A Systematic Review of Personality Disorders and Health Outcomes
Q37416027A comparison of borderline personality disorder with and without eating disorders
Q30428539A developmental neuroscience of borderline pathology: emotion dysregulation and social baseline theory
Q22241549A feasibility study of mindfulness-based cognitive therapy for individuals with borderline personality disorder
Q50880331A momentary assessment study of the reputed emotional phenotype associated with borderline personality disorder.
Q37704891A pilot randomized controlled trial of Dialectical Behavior Therapy with and without the Dialectical Behavior Therapy Prolonged Exposure protocol for suicidal and self-injuring women with borderline personality disorder and PTSD.
Q40493860A psychometric investigation of gender differences and common processes across borderline and antisocial personality disorders.
Q38004087A systematic review of dialectical behavior therapy for the treatment of eating disorders
Q51749419Abnormalities in gray matter volume in patients with borderline personality disorder and their relation to lifetime depression: A VBM study.
Q34510610Affective disorders among patients with borderline personality disorder
Q30842229Anger and aggression in borderline personality disorder and attention deficit hyperactivity disorder - does stress matter?
Q34623377Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis?
Q48797436Associations between identity diffusion, Axis II disorder, and psychopathology in inpatients with borderline personality disorder
Q92557336Autism and psychosis as diametrical disorders of embodiment
Q43503779Axis I and II comorbidity and psychosocial functioning in female adolescents with borderline personality disorder
Q57820405Body dysmorphic disorder in patients with borderline personality disorder: prevalence, clinical characteristics, and role of childhood trauma
Q33569687Borderline personality disorder and comorbid addiction: epidemiology and treatment
Q92556025Borderline personality disorder and emotion dysregulation
Q36254513Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment
Q35951671Borderline personality symptoms in short-term and long-term abstinent alcohol dependence
Q39000906Bullying involvement in relation to personality disorders: a prospective follow-up of 508 inpatient adolescents
Q34274132Characterizing eating disorders in a personality disorders sample
Q36033769Characterizing emotional dysfunction in borderline personality, major depression, and their co-occurrence
Q43659226Childhood maltreatment in patients with somatization disorder
Q36915195Childhood trauma, borderline personality, and eating disorders: a developmental cascade
Q46655728Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy
Q53423501Comorbid Diagnosis of Psychotic Disorders in Borderline Personality Disorder: Prevalence and Influence on Outcome.
Q38140705Comorbid personality disorders and violent behavior in psychotic patients
Q34406137Comorbidity of borderline personality disorder and posttraumatic stress disorder in the U.S. population
Q36246780Comorbidity study of borderline personality disorder: applying association rule mining to the Taiwan national health insurance research database
Q41137973Comparing Effectiveness of Treatments for Borderline Personality Disorder in Communal Mental Health Care: The Oulu BPD Study
Q50582894Construct Validity of the DSM-5 Section III Personality Trait Profile for Borderline Personality Disorder.
Q35217429Correlates, stability and predictors of borderline personality disorder among previously suicidal youth
Q36510893Defense mechanisms reported by patients with borderline personality disorder and axis II comparison subjects over 16 years of prospective follow-up: description and prediction of recovery
Q51858385Depressive comorbidity in personality disorders.
Q50059215Description and prediction of time-to-attainment of excellent recovery for borderline patients followed prospectively for 20 years
Q37051670Developmental differences in diffusion tensor imaging parameters in borderline personality disorder.
Q33553137Dialectical behavior therapy for substance abusers
Q36088760Differences in Facial Emotion Recognition between First Episode Psychosis, Borderline Personality Disorder and Healthy Controls
Q34559452Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity
Q34352918Does comorbid substance use disorder exacerbate borderline personality features? A comparison of borderline personality disorder individuals with vs. without current substance dependence
Q43075511Dysregulation of regional endogenous opioid function in borderline personality disorder.
Q36359767EXPLORING PERSONALITY DIAGNOSIS STABILITY FOLLOWING ACUTE PSYCHOTHERAPY FOR CHRONIC POSTTRAUMATIC STRESS DISORDER
Q85075488Eating disorder symptoms and borderline personality symptomatology
Q36083269Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder - a pilot study
Q48051504Evaluation of changes in prescription medication use after a residential treatment programme for borderline personality disorder.
Q37841775Evidence-based pharmacotherapy for personality disorders
Q36403227Examining challenging behaviors of clients with borderline personality disorder
Q45247344Examining the course and outcome of individuals diagnosed with schizophrenia and comorbid borderline personality disorder
Q60640286Exploring General Practitioners’ Views and Experiences of Providing Care to People with Borderline Personality Disorder in Primary Care: A Qualitative Study in Australia
Q37059238Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up
Q86877345Focused vs. Broad enhanced cognitive behavioral therapy for bulimia nervosa with comorbid borderline personality: A randomized controlled trial
Q38831637Genetic and environmental influences on the codevelopment among borderline personality disorder traits, major depression symptoms, and substance use disorder symptoms from adolescence to young adulthood
Q33626096Hypothalamic pituitary thyroid axis and exposure to interpersonal violence in childhood among women with borderline personality disorder
Q36605170Identifying latent trajectories of personality disorder symptom change: growth mixture modeling in the longitudinal study of personality disorders
Q33824370Impact of therapist change after initial contact and traumatic burden on dropout in a naturalistic sample of inpatients with borderline pathology receiving dialectical behavior therapy
Q52898956Impaired decision making and feedback evaluation in borderline personality disorder.
Q34459466In-depth study of personality disorders in first-admission patients with substance use disorders
Q37964559Long-term outcomes in borderline psychopathology: old assumptions, current findings, and new directions
Q36416810Management of borderline personality disorder
Q64938243Mentalization-based treatment or psychodynamic treatment programmes for patients with borderline personality disorder - the impact of clinical severity.
Q92649835Metacognitive Therapy of Early Traumatized Patients With Borderline Personality Disorder: A Phase-II Baseline Controlled Trial
Q36719875New frontiers in the role of hospitalization for patients with personality disorders
Q37345068New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: findings from the Collaborative Longitudinal Personality Disorders Study
Q37935806Off-label use of atypical antipsychotics in personality disorders.
Q36142670Pathological personality traits among patients with absent, current, and remitted substance use disorders
Q35016163Personality and psychopathology: the dangers of premature closure
Q37703213Personality disorders and mood disorders: perspectives on diagnosis and classification from studies of longitudinal course and familial associations
Q34498313Personality disorders and the persistence of substance use disorders: A reanalysis of published NESARC findings
Q36072750Personality disorders associated with full and partial posttraumatic stress disorder in the U.S. population: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions
Q50611471Personality disorders in the workplace.
Q24234749Pharmacological interventions for borderline personality disorder
Q94348315Pharmacological interventions for people with borderline personality disorder
Q37589844Prevalence and risk factors for irritable bowel syndrome in recovered and non-recovered borderline patients over 10 years of prospective follow-up
Q37252602Psychiatric Comorbidity in Alcohol Dependence
Q37055695Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients
Q91477754Psychometric properties of the Spanish version of the involvement evaluation questionnaire in caregivers of patients with borderline personality disorders
Q42163532Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics
Q34771403Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up
Q36084686Rejection sensitivity and symptom severity in patients with borderline personality disorder: effects of childhood maltreatment and self-esteem
Q39429897Risk stratification for the early diagnosis of borderline personality disorder using psychiatric co-morbidities
Q34603448Severity of anxiety symptoms reported by borderline patients and Axis II comparison subjects: description and prediction over 16 years of prospective follow-up
Q48122288Structural alterations in white-matter tracts connecting (para-)limbic and prefrontal brain regions in borderline personality disorder
Q51660649Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments.
Q44016774Suicide attempts in major depressed patients with personality disorder
Q35469922The 10-year course of PTSD in borderline patients and axis II comparison subjects
Q26801767The Lifetime Course of Borderline Personality Disorder
Q55262466The Risk Factors of the Alcohol Use Disorders-Through Review of Its Comorbidities.
Q39812349The clinical trajectory of patients with borderline personality disorder
Q33875755The contribution of familial internalizing and externalizing liability factors to borderline personality disorder
Q96135685The course of (comorbid) trauma-related, dissociative and personality disorders: two year follow up of the Friesland study cohort
Q36552125The course of anxiety disorders other than PTSD in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study
Q33729569The course of eating disorders in patients with borderline personality disorder: a 10-year follow-up study
Q35569762The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10‐year follow‐up study
Q47870860The impact of childhood traumas, depressive and anxiety symptoms on the relationship between borderline personality features and symptoms of adult attention deficit hyperactivity disorder in Turkish university students
Q37141463The impact of posttraumatic stress disorder on the symptomatology of borderline personality disorder
Q36084677The relationship between borderline symptoms and vantage perspective during autobiographical memory retrieval in a community sample
Q37449605The relationship of chronic medical illnesses, poor health-related lifestyle choices, and health care utilization to recovery status in borderline patients over a decade of prospective follow-up
Q46807192Three-week inpatient Cognitive Evolutionary Therapy (CET) for patients with personality disorders: evidence of effectiveness in symptoms reduction and improved treatment adherence
Q36395463Time course of facial emotion processing in women with borderline personality disorder: an ERP study
Q34068038Trauma-related altered states of consciousness in women with BPD with or without co-occurring PTSD.
Q47366572Trauma-related dissociation: Psychological features and psychophysiological responses to script-driven imagery in borderline personality disorder
Q36813316Treatment of borderline personality disorder and co-occurring anxiety disorders
Q50596337Treatment of personality disorder
Q33823729Treatment preference among suicidal and self-injuring women with borderline personality disorder and PTSD.
Q48286636Treatment progress in medium security hospital settings for women: changes in symptoms, personality and service need from admission to discharge
Q34817261Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study
Q37685521What Works in the Treatment of Borderline Personality Disorder
Q39221611What changes when? The course of improvement during a stage-based treatment for suicidal and self-injuring women with borderline personality disorder and PTSD.
Q36192004What is the impact of child abuse on gray matter abnormalities in individuals with major depressive disorder: a case control study
Q90590661What we do, do not, and need to know about comorbid depression and personality disorders
Q34584223World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders
Q82387728[Psychopharmacotherapy in adolescents with borderline personality disorder in inpatient and outpatient psychiatric treatment]

Search more.